P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer's disease: Preliminary observations

Neurobiology of Aging

Volumn 36, Issue 9, 2015, Pages 2475-2482

  Chiu, Catherine ^a   Miller, Miles C ^a   Monahan, Renée ^b   Osgood, Doreen P ^a   Stopa, Edward G ^a,b   Silverberg, Gerald D ^a  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

Aging; Alzheimer's disease; A ; Blood brain barrier; P glycoprotein

Indexed keywords

AMYLOID BETA PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; AMYLOID; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ADULT; AGED; AGING; ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; BIOACCUMULATION; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; MICROVASCULATURE; MIDDLE AGED; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUALITATIVE ANALYSIS; RAT; RNA ANALYSIS; VERY ELDERLY; YOUNG ADULT; AGE; BLOOD BRAIN BARRIER; BRAIN; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; BLOOD-BRAIN BARRIER; BRAIN; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PEPTIDE FRAGMENTS; PSYCHIATRIC STATUS RATING SCALES; RNA, MESSENGER; YOUNG ADULT;

EID: 84940467298     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.05.020     Document Type: Article

References (40)

1. Anonymous Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute working group on diagnostic criteria for the neuropathological assessment of Alzheimer's disease. Neurobiol. Aging 1997, 18(4 suppl):S1-S2.
2. Bauer B., Hartz A.M., Pekcec A., Toellner K., Miller D.S., Potschka H. Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling. Mol. Pharmacol. 2008, 73:1444-1453.
3. Bendayan R., Lee G., Bendayan M. Functional expression and localization of P-glycoprotein at the blood brain barrier. Microsc. Res. Tech. 2002, 57:365-380.
4. Bijal P. Harvard Brain Bank Faces Shortage of "Normal" Brains 2003, National Geographic, Washington, D.C. http://news.nationalgeographic.com/news/2003/08/0828_030828_tvbrainbank_2.html.
5. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
6. Braak H., Thal D.R., Ghebremedhin E., Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J.Neuropathol. Exp. Neurol. 2011, 70:960-969.
7. Brenn A., Grube M., Peters M., Fischer A., Jedlitschky G., Kroemer H.K., Warzok R.W., Vogelgesang S. Beta-amyloid downregulates MDR1-P-glycoprotein (Abcb1) expression at the blood-brain barrier in mice. Int. J. Alzheimers Dis. 2011, 2011:690121.
8. Church R.M., Miller M.C., Freestone D., Chiu C., Osgood D.P., Machan J.T., Messier A.A., Johanson C.E., Silverberg G.D. Amyloid-beta accumulation, neurogenesis, behavior, and the age of rats. Behav. Neurosci. 2014, 128:523-536.
9. Cirrito J.R., Deane R., Fagan A.M., Spinner M.L., Parsadanian M., Finn M.B., Jiang H., Prior J.L., Sagare A., Bales K.R., Paul S.M., Zlokovic B.V., Piwnica-Worms D., Holtzman D.M. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J.Clin. Invest. 2005, 115:3285-3290.
10. Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A.M., Armstrong D.L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., Zlokovic B. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 2003, 9:907-913.
11. Donahue J.E., Flaherty S.L., Johanson C.E., Duncan J.A., Silverberg G.D., Miller M.C., Tavares R., Yang W., Wu Q., Sabo E., Hovanesian V., Stopa E.G. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol. 2006, 112:405-415.
12. Fromm M.F. Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol. Sci. 2004, 25:423-429.
13. Guiot Y., Rahier J. Validation of nonradioactive in situ hybridization as a quantitative approach of messenger ribonucleic acid variations: a comparison with northern blot. Diagn. Mol. Pathol. 1997, 6:261-266.
14. Higo N., Oishi T., Yamashita A., Matsuda K., Hayashi M. Quantitative non-radioactive in situ hybridization study of GAP-43 and SCG10 mRNAs in the cerebral cortex of adult and infant macaque monkeys. Cereb. Cortex 1999, 9:317-331.
15. Jeynes B., Provias J. An investigation into the role of P-glycoprotein in Alzheimer's disease lesion pathogenesis. Neurosci. Lett. 2011, 487:389-393.
16. Juliano R.L., Ling V. Asurface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 1976, 455:152-162.
17. Lam F.C., Liu R., Lu P., Shapiro A.B., Renoir J.M., Sharom F.J., Reiner P.B. Beta-amyloid efflux mediated by p-glycoprotein. J.Neurochem. 2001, 76:1121-1128.
18. Mackic J.B., Bading J., Ghiso J., Walker L., Wisniewski T., Frangione B., Zlokovic B.V. Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions. Vascul Pharmacol. 2002, 38:303-313.
19. Mann G.E., Zlokovic B.V., Yudilevich D.L. Evidence for a lactate transport system in the sarcolemmal membrane of the perfused rabbit heart: kinetics of unidirectional influx, carrier specificity and effects of glucagon. Biochim. Biophys. Acta 1985, 819:241-248.
20. Mawuenyega K.G., Sigurdson W., Ovod V., Munsell L., Kasten T., Morris J.C., Yarasheski K.E., Bateman R.J. Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 2010, 330:1774.
21. Miller M.C., Tavares R., Johanson C.E., Hovanesian V., Donahue J.E., Gonzalez L., Silverberg G.D., Stopa E.G. Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease. Brain Res. 2008, 1230:273-280.
22. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486.
23. Newell K.L., Hyman B.T., Growdon J.H., Hedley-Whyte E.T. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J.Neuropathol. Exp. Neurol. 1999, 58:1147-1155.
24. Pascale C.L., Miller M.C., Chiu C., Boylan M., Caralopoulos I.N., Gonzalez L., Johanson C.E., Silverberg G.D. Amyloid-beta transporter expression at the blood-cerebrospinal fluid barrier is age-dependent. Fluids Barriers CNS 2011, 8:21.
25. Querfurth H.W., LaFerla F.M. Alzheimer's disease. N.Engl. J. Med. 2010, 362:329-344.
26. R: A Language and Environment for Statistical Computing 2008, R Development Core Team, R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org.
27. Sarkadi B., Homolya L., Szakács G., Váradi A. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physio.l Rev. 2006, 86:1179-1236.
28. Shibata M., Yamada S., Kumar S.R., Calero M., Bading J., Frangione B., Holtzman D.M., Miller C.A., Strickland D.K., Ghiso J., Zlokovic B.V. Clearance of Alzheimer's amyloid-beta (1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J.Clin. Invest. 2000, 106:1489-1499.
29. Silverberg G.D., Messier A.A., Miller M.C., Machan J.T., Majmudar S.S., Stopa E.G., Donahue J.E., Johanson C.E. Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging. J.Neuropathol. Exp. Neurol. 2010, 69:1034-1043.
30. Silverberg G.D., Miller M.C., Messier A.A., Majmudar S., Machan J.T., Donahue J.E., Stopa E.G., Johanson C.E. Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging. J.Neuropathol. Exp. Neurol. 2010, 69:98-108.
31. Sisodiya S.M., Lin W.R., Squier M.V., Thom M. Multidrug-resistance protein 1 in focal cortical dysplasia. Lancet 2001, 357:42-43.
32. van Assema D.M., Lubberink M., Bauer M., van der Flier W.M., Schuit R.C., Windhorst A.D., Comans E.F., Hoetjes N.J., Tolboom N., Langer O., Müller M., Scheltens P., Lammertsma A.A., van Berckel B.N. Blood-brain barrier P-glycoprotein function in Alzheimer's disease. Brain 2012, 135:181-189.
33. van Assema D.M., Lubberink M., Boellaard R., Schuit R.C., Windhorst A.D., Scheltens P., Lammertsma A.A., van Berckel B.N. P-Glycoprotein function at the blood-brain barrier: effects of age and gender. Mol. Imaging Biol. 2012, 14:771-776.
34. Vogelgesang S., Cascorbi I., Schroeder E., Pahnke J., Kroemer H.K., Siegmund W., Kunert-Keil C., Walker L.C., Warzok R.W. Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics 2002, 12:535-541.
35. Vogelgesang S., Warzok R.W., Cascorbi I., Kunert-Keil C., Schroeder E., Kroemer H.K., Siegmund W., Walker L.C., Pahnke J. The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease. Curr. Alzheimer Res. 2004, 1:121-125.
36. Zhao Z., Liu W., Su Y., Zhu J., Zheng G., Luo Q., Jin X. Evaluation of biodistribution and safety of adenovirus vector containing MDR1 in mice. J.Exp. Clin. Cancer Res. 2010, 29:1.
37. Zlokovic B.V. Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier. Pharm. Res. 1995, 12:1395-1406.
38. Zlokovic B.V. Clearing amyloid through the blood-brain barrier. J.Neurochem. 2004, 89:807-811.
39. Zlokovic B.V., Begley D.J., Chain-Eliash D.G. Blood-brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine). Brain Res. 1985, 336:125-132.
40. Zloković B.V., Lipovac M.N., Begley D.J., Davson H., Rakić L. Transport of leucine-enkephalin across the blood-brain barrier in the perfused guinea pig brain. J.Neurochem. 1987, 49:310-315.